Company profile: TriVascular
1.1 - Company Overview
Company description
- Provider of new medical devices delivering optimal solutions for endovascular aortic repair (EVAR).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TriVascular
Renovacor
HQ: United States
Website
- Description: Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renovacor company profile →
enVVeno Medical
HQ: United States
Website
- Description: Provider of bioprosthetic devices for cardiovascular surgeries, including VenoValve, a surgically implanted one-way valve to restore proper blood flow in the femoral vein for patients with deep venous Chronic Venous Insufficiency (CVI), and enVVe, a non-surgical, transcatheter-based replacement venous valve for minimally invasive treatment of CVI in the deep veins of the leg.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full enVVeno Medical company profile →
Intershunt
HQ: United States
Website
- Description: Provider of a catheter-based, minimally invasive percutaneous atrial shunt system designed to relieve left atrial pressure and improve breathing in heart failure patients; currently under development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intershunt company profile →
CryoTherapeutics
HQ: Belgium
Website
- Description: Provider of a proprietary intracoronary cryotherapy system (CTS) for the treatment of coronary artery disease, designed to stabilize high-risk plaque lesions and potentially prevent heart attacks without leaving a stent. Offerings include a patented catheter and console interface for localized cryoenergy delivery, and ongoing clinical trials, including the POLARSTAR study, to demonstrate safety and efficacy for regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CryoTherapeutics company profile →
Middle Peak Medical
HQ: United States
Website
- Description: Provider of novel medical device technology to treat mitral valve disease, offering a proprietary device applicable to percutaneous catheter-based intervention and minimally invasive or open-heart cardiac surgery, with a focus on development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Middle Peak Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TriVascular
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TriVascular
2.2 - Growth funds investing in similar companies to TriVascular
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TriVascular
4.2 - Public trading comparable groups for TriVascular
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →